Inotrem
FranceEntry
2019
Hold
7yr
Status
Active
Who owns Inotrem?
Inotrem is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2019. Across its history, Inotrem has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare / Biotech
Ownership history
2 ownership periods
Active
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Andera PartnersActive
present · BioDiscovery 4 · 2013 · VC
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
Switzerland
US
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Inotrem
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Inotrem?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Inotrem.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue